Conditions: 4 mM 15% pyrenyl-actin, 5 nM SpArp2/3 complex, and 1 mM N-WASP-VCA, or 3 mM 30% pyrenylactin, 5 nM BtArp2/3 complex and 1 mM N-WASP-VCA. CK-548 was insoluble at 200 mM under the conditions used for this assay. The maximum polymerization rate of actin alone under these conditions was 4.6 nM s 21 . d, Effect of CK-666 and CK-869 on the polymerization of actin with bovine and yeast Arp2/3 complexes. Conditions as in c with either 3 mM 30% pyrenyl-actin and 5 nM BtArp2/3 complex or 4 mM 20% pyrenyl-actin plus 20 nM SpArp2/3 complex or 5 nM ScArp2/3 complex. Both compounds reduced the maximum polymerization rate of samples with BtArp2/3 complex to the basal rate without Arp2/3 complex, but CK869 did not inhibit either yeast Arp2/3 complex. e, Fluorescence micrographs of the products of actin polymerization assays stained with Alexa 488-phalloidin. Actin (3.6 mM) was polymerized with 6 nM HsArp2/3 complex, 300 nM Cdc42, 100 mM CK-636 and 100 nM of a WASP construct lacking only its N-terminal Ena/Vasp homology domain, WASP-105-502. Scale bar, 20 mm.
controls for experiments with cells ( Fig. 2g ). Supplementary Table 2 lists one inactive compound from each class.
The following control experiments showed that both compounds interact with Arp2/3 complex rather than actin or WASP. At 20 mM, neither compound inhibited polymerization of actin alone or polymerization stimulated by the FH2 domain of formin Cdc12p (Cdc12(FH2); Fig. 1b ), so neither compound interacts directly with actin. As actin can polymerize on its own, neither compound eliminated actin polymerization in mixtures with Arp2/3 complex and WASP or a carboxy-terminal construct of Neural Wiskott-Aldrich syndrome protein (N-WASP-VCA) ( Fig. 1c, d ). Both compounds inhibited polymerization stimulated by HsArp2/3 complex and ActA, an Arp2/3 complex activating factor from Listeria monocytogenes 2 , suggesting that they do not act on WASP ( Supplementary Fig. 1 ). A fluorescence anisotropy assay showed that neither compound had a large effect on Arp2/3 complex binding N-WASP-VCA ( Supplementary Fig. 2 ). The affinity of rhodamine-N-WASP-VCA for BtArp2/3 complex was the same with 50 mM CK-636 (K d 5 470 6 50 nM) as controls (K d 5 510 6 30 nM), but 50 mM CK-548 decreased the affinity approximately twofold (K d 5 1.0 6 0.2 mM).
We used a Listeria motility assay to determine whether CK-636 and CK-548 can inhibit actin polymerization mediated by Arp2/3 complex in live cells. Both compounds reduced the formation of actin filament comet tails by Listeria in infected SKOV3 cells ( Fig. 2a -c). The concentration dependence of this inhibition gave IC 50 values of 22 mM for CK-636 and 31 mM for CK-548. We used the actin polymerization and Listeria comet tail assays to search for more potent inhibitors related to CK-636 and CK-548.
Compound CK-0944666 (abbreviated CK-666) has a fluorobenzene rather than the thiophene ring of CK-636 ( Fig. 1a ). CK-666 was a better inhibitor of actin polymerization with either BtArp2/3 complex (IC 50 5 32 mM for CK-636 verses 17 mM for CK-666) or SpArp2/3 complex (IC 50 5 24 mM for CK-636 versus 5 mM for CK-666) ( Fig. 1d , Supplementary Table 1 ). Both CK-636 and CK-666 had IC 50 values of 4 mM for inhibiting HsArp2/3 complex. CK-666 reduced actin polymerization around intracellular Listeria to background levels ( Fig. 2d , e and g) at lower concentrations than CK-636 ( Fig. 2c ). Actin filament haloes and comet tails reformed when the compounds were removed after one hour of treatment ( Fig. 2f, g) . Inactive control compound CK-689 had no effect on comet tail formation ( Fig. 2g ).
CK-0157869 (abbreviated CK-869) has methoxy groups in the ortho and para positions replacing the ortho-hydroxy and metachlorine substituents of CK-548 ( Fig. 1a ). CK-869 inhibited actin polymerization with BtArp2/3 complex similarly to CK-548 (IC 50 5 11 mM for both compounds), but CK869 inhibited comet tail formation by Listeria more effectively (IC 50 5 7 mM for CK-869 versus 31 mM for CK-548). Like CK-548, CK-869 did not inhibit either budding or fission yeast Arp2/3 complexes ( Fig. 1d ).
Both CK-548 and CK-636 also inhibited the formation of podosomes by the THP-1 monocyte cell line ( Fig. 2h -k). Podosomes are adhesive structures that depend on Arp2/3 complex, WASP and actin polymerization 3 . Podosomes also depend on microtubules 4 , but neither CK-548 or CK-636 at 100 mM disrupted the microtubule network in THP-1 cells ( Supplementary Fig. 3 ). Neither class of compound shows irreversible or off-target morphological effects on cells, such as apoptosis, at concentrations up to 100 mM over 24 h. Our most potent compound, CK-666, had no effect on the mitotic index of SKOV cells at concentrations up to 80 mM, while inhibiting actin assembly around Listeria completely at 10 mM. Fifty micromolar CK-666 or CK-869 each altered the morphology and slightly slowed but did not stop the gliding motility of fish keratocytes (data not shown), as expected, as ,10% of Arp2/3 complex (,500 nM) would still be active. Thus Listeria comet tails and monocyte podosomes are more sensitive than lamellar motility to inhibition of Arp2/3 complex.
We determined X-ray crystal structures of BtArp2/3 complex with either CK-636 or CK-548 bound, using molecular replacement with the apo-form BtArp2/3 complex as the search model (PDB accession 1K8K) 5 . Structures of Arp2/3 complex co-crystallized with the compounds and with compounds soaked into the crystals were nearly identical, but the resolution of soaked crystals was higher (2.70 Å for CK-636 and 2.85 Å for CK-548, Supplementary Table 3 ). As in previous crystal structures of BtArp2/3 complex 5-7 , none of these structures had appreciable electron density for subdomains 1 and 2 of Arp2, which appears only after chemical crosslinking 7 .
After one round of rigid body refinement, strong F o 2 F c electron density was present at the interface between Arp2 and Arp3 in maps calculated with data from crystals soaked in 1 mM CK-636 ( Fig. 3 ). This density improved on further refinement ( Supplementary Fig. 4a ), and CK-636 was modelled into the density when the R f was 29.2%. CK-636 binds in a pocket between subdomain 4 of Arp2 and subdomain 1 of Arp3. The contact surface is mainly hydrophobic and buries 161 Å 2 of the accessible surface of Arp2 and 79 Å 2 of Arp3. CK-636 forms hydrogen bonds with two residues in the pocket. The side chain of Asp 248 forms a hydrogen bond with the nitrogen in the indole ring of the inhibitor, and the backbone amide of Ala 203 forms a hydrogen bond with the carbonyl oxygen on the linker between the two ring systems. Both trans and cis conformations of the amide functional group of CK-636 fit into the electron density with the hydrogen bonds described above preserved in both conformations.
Because trans-amides are generally 1-5 kcal mol 21 more stable than cis-amides in solution 8 , and the cis conformation is rarely observed in small molecules, we modelled CK-636 in the trans conformation.
A difference electron density map shows that CK-636 causes minor conformational changes in the complex (Fig. 3b ). Arp2 Arg 250 from b-strand 13 rotates out of the pocket and adopts an extended conformation. Arp2 Ala 203 from the loop (residues 199-208) connecting a-helices aE and aF moves towards the pocket, causing the side chain of Leu 198 to adopt a new rotamer. These changes and small changes in the backbone of residues surrounding the pocket result in an overall r.m.s. deviation of 0.63 Å for an overlay of subdomains 3 and 4 (191 Ca atoms) of Arp2 with and without inhibitor bound.
We modelled CK-666 into the CK-636 binding pocket with the aromatic fluorine pointed towards a concave surface in the back wall of the pocket formed by Tyr 202 in Arp2 and residues 118 to 120 in Arp3 ( Supplementary Fig. 6 ). One hundred steps of conjugate gradient minimization in CNS 9 showed that CK-666 is stable in this conformation and does not clash with residues in the pocket. The fluorine atom provides additional van der Waals interactions with the back wall of the pocket, and the benzene ring completely fills the hydrophobic pocket created by Ile 252, Tyr 202 and the aliphatic portion of Thr 119. These interactions may allow CK-666 to bind more tightly than CK-636.
During formation of a branch Arp2 moves 31 Å relative to Arp3 from its position in inactive Arp2/3 complex 10 , so the location of the CK-636 binding pocket between Arp2 and Arp3 suggests that CK-636 and CK-666 lock Arp2/3 complex in an inactive conformation. CK-636 at a concentration of 100 mM did not interfere with N-WASP-VCA binding to Arp2/3 complex ( Supplementary Fig. 2 ), but it prevented WASP-VCA binding from increasing the fluorescence of Arp2/3 complex loaded with etheno-ATP ( Supplementary Fig. 5 ). Thus CK-636 inhibits a conformational change caused by activator binding. This supports the hypothesis that CK-636 locks the complex in an inactive conformation.
The residues contributed by Arp2 and Arp3 to form the CK-636 binding pocket are conserved across a broad range of species (Supplementary Table 4 ), so we expect CK-636 and CK-666 will be useful for inhibiting Arp2/3 complex from diverse species. These residues are also conserved in actin, but CK-636 does not inhibit actin polymerization at concentrations up to 200 mM. Only half of the binding site is available on an actin monomer, and the two halfsites are not juxtaposed in actin filaments 11 .
CK-548 has a single stereocentre and was used as a racemic mixture in our experiments. The 2S enantiomer binds in a hydrophobic cavity in the core of the Arp3 subunit (Fig. 4a, b and Supplementary Fig. 4b ).
The isolated 2R enantiomer, which does not fit in the binding pocket, should provide a useful control for in vivo experiments. Binding of CK-548 requires a substantial conformational change: the loop (residues 76-85) connecting b6 (73-75) and aB (86-98) in subdomain 1 of Arp3 flips upward 7.2 Å , exposing the binding site in the hydrophobic core of Arp3 (Fig. 4b, c ). CK-548 contacts 239 Å 2 of the inner surface of this cavity, which includes residues Cys 12, Ile 78, Trp 86, Met 89, Met 93 and Leu 112. A hydrogen bond between the side chain amide of Asn 118 and the carbonyl oxygen of CK-548 anchors the inhibitor to the loop between b7 (110-114) and aC (120-132), which forms the bottom lip of the cavity. The ability of CK-548 to bind crystallized Arp2/3 complex suggests that the b6/aB loop can open the hydrophobic binding pocket both in crystals and in solution, even in the absence of inhibitor. The average B-factor for all residues in the loop is 63 Å 2 in the closed conformation and 82 Å 2 in the open conformation, suggesting that the loop is more flexible when open.
When modelled into the CK-548 binding site, the para-methoxy group of CK-869 projects towards the upper lip of the pocket and is sandwiched by the side chains of Ile 78, Glu 84 and Met 89 ( Supplementary Fig. 7) . The ortho-methoxy group points towards a crease formed at the ends of strands b1 and b7, which could be exploited to design higher affinity inhibitors.
Both CK-548 and CK-869 inhibited human and bovine Arp2/3 complexes, but neither inhibited budding or fission yeast Arp2/3 Colour code: Arp3, orange; Arp2, pink; actin-related protein complex, subunit 1 (ARPC1), green; ARPC2, cyan; ARPC3, magenta, ARPC4, blue; ARPC5, yellow. a, Ribbon diagram with (right) a detail of binding pocket. b, Stereo diagram of an F o 2 F c electron density map, showing changes caused by CK-636. Positive (blue) and negative (red) difference densities indicate the position of CK-636 and small conformational changes of the protein. The apo-structure (PDB accession 1K8K) is shown in green stick representation, and the final structure in yellow. The density is contoured at 3.5s, and was generated using structure factors calculated after one round of rigid body refinement and the data for the CK-636-soaked crystal. complexes (Fig. 1c, d) . The residues that contact CK-548 are conserved in Arp2/3 complexes of most mammals, but tryptophan replaces Met 93 at the back of the CK-548 binding pocket in many other species, including budding and fission yeast (Supplementary Table 5 ). The bent side chain of Met 93 allows CK-548 to bind, but tryptophan at this position blocks binding to non-mammalian Arp3 and actin.
The mechanism of action of CK-548/869 is less apparent than that of CK-636/666. A fluorescence anisotropy assay showed that CK-548 decreased the affinity of rhodamine-labelled N-WASP-VCA for Arp2/3 complex twofold, but this should be inconsequential under the conditions of our assay ( Supplementary Fig. 2) . The conformation induced by CK-548/869 must interfere with one or more of the reactions along the pathway to branch formation, such as binding of the pointed end of Arp3 to a mother filament 10 , nucleotide binding to Arp3, or conformational changes that activate branch formation.
METHODS SUMMARY
Compounds were purchased from Chemdiv: CK-0944636 (catalogue number 8012-5103), CK-0993548 (K205-1650), CK-0944666 (8012-5153) and CK-0157869 (K205-0942). We purified native Arp2/3 complex from human platelets 12 , bovine thymus 6 , Schizosaccharomyces pombe 13 and Saccharomyces cerevisiae (Supplementary Methods), actin from chicken skeletal muscle 14 , recombinant full length HsWASP from Freestyle 293-FS cells (Invitrogen), HsWASP (residues 105-502), HsWASP-VCA (residues 428-502), Cdc42 12 , N-WASP-VCA (residues 428-505) (Supplementary Methods), GST-ActA (residues 36-170) (Supplementary Methods) and S. pombe Cdc12p(FH2) (residues 973-1390) 15 from Escherichia coli. We used standard assays to measure polymerization of pyrenyl-actin 16 and to visualize actin filaments by fluorescence microscopy 17 . Binding of etheno-ATP to Arp2/3 complex was performed as described previously with slight modifications 18 . We crystallized BtArp2/3 complex 7 with either 0.5 mM CK-548 or 1 mM CK-636 in DMSO or soaked these compounds into crystals for 24 h before freezing in liquid nitrogen. Diffraction data were collected at beamline X29A at Brookhaven National Laboratories. SKOV3 cells were infected with L. monocytogenes and fixed with 2% formaldehyde, permeabilized with 0.1% Triton-X in PBS, stained with Listeria antibody (US Biologics) and Alexa Fluor 568 phalloidin (Molecular Probes), and imaged by fluorescence microscopy. We used an Isodata threshold on background-subtracted images of Listeria to isolate individual bacteria and measure the ratio of colocalized actin to Listeria fluorescence. Monocyte THP-1 cells were differentiated in 50 nM phorbol myristate acetate (Sigma-Aldrich Fluka) to form podosomes before treatment with compounds. Black molly keratocytes 19 were observed by time-lapse phase contrast microscopy. 
